Oracle collaborates with MyDIGITAL Corporation to help advance Malaysia’s Digital Economy Blueprint and National 4IR Policy by equipping local talents with in-demand digital skills, strengthening the IT talent pipeline, and fostering a value-based, innovation-led economy.

KUALA LUMPUR, Malaysia, April 2, 2026 /PRNewswire/ — Oracle and MyDIGITAL Corporation, a monitoring agency under the Ministry of Digital overseeing the implementation of the Malaysia Digital Economy Blueprint and the National Fourth Industrial Revolution (4IR) Policy, today announced a collaboration to deliver skills training to 300,000 students and professionals across Malaysia, aiming to boost employability and support career growth by 2029. 

(L-R) Chin Ying Loong, SVP and regional managing director, Oracle, ASEAN & SAGE, Ir. Wan Murdani Wan Mohamad, VP, Digital Adoption⁠, Malaysia Digital Economy Corporation (MDEC), Royce Teoh, managing director, Oracle, Malaysia, YB Gobind Singh Deo, Minister of Digital, Malaysia, YB Tuan Ma Sivanesan, deputy secretary general, Ministry of Digital, Malaysia, Chris Chelliah, SVP, Technology, Oracle, Japan & Asia Pacific and Adrian Marcellus, CEO, MYDIGITAL Corporation

The collaboration with MyDIGITAL Corporation gives students and professionals access to digital training and foundational certifications to prepare them for future jobs. This includes over 200 hours of learning and certifications, with full structured learning paths, delivered over three years in technologies such as Oracle Cloud Infrastructure (OCI), OCI Generative AI, OCI Data Science, Oracle APEX, OCI DevOps, and OCI Security.

“Strong investment momentum in Malaysia’s digital economy is reinforcing the country’s ambition to become an AI Nation by 2030 and cementing its position as a leading digital innovation hub in Southeast Asia,” said YB Gobind Singh Deo, Minister of Digital, Malaysia. “MyDIGITAL Corporation’s strategic skills development initiative with Oracle, alongside the Oracle Cloud Malaysia Region, will help build a high-caliber digital workforce while accelerating innovation and supporting Malaysia’s long-term digital and economic growth. We continue to encourage greater provision of lifelong learning opportunities from both the public and private sectors to meet the rising demand for AI talent and strengthen Malaysia’s competitiveness in the global digital economy.”

The program will be delivered for free as a digital learning experience through Oracle MyLearn, Oracle’s comprehensive training and enablement platform from Oracle University, used by millions of technology trainees around the world. It provides foundational cloud training, advancing to professional certifications and additional learning tailored to skill level and goals. Learners can earn badges alongside professional certifications, showcasing readiness for specialized roles and helping employers identify qualified candidates. This complements the existing free digital awareness and literacy modules available in Rakyat Digital that is powered by MyDIGITAL Corporation. To provide a seamless user experience, Oracle MyLearn will be integrated into Rakyat Digital by June 2026.

“By unifying every layer of the AI stack, Oracle helps organizations across industries harness AI innovations, transform operations, and build critical digital skills,” said Royce Teoh, managing director, Oracle Malaysia. “As Malaysia aims to become a regional AI Nation by 2030, the Oracle Cloud Malaysia Region and our collaboration with MyDIGITAL Corporation can strengthen the local digital talent pipeline, foster a vibrant digital ecosystem, and advance the nation’s AI ambitions.”

Oracle University provides access to some of the world’s leading technology experts and practitioners to support cloud technology training and certification all over the world. More than 20 million hours of Oracle University learning content have been viewed globally, and the program has trained over three million Oracle-certified professionals worldwide with participants from Malaysia.

About MyDIGITAL Corporation
MyDIGITAL Corporation is a monitoring agency and operates as a Strategic Change Management Office under the Ministry of Digital, overseeing the implementation of the Malaysia Digital Economy Blueprint and the National 4IR Policy. It serves as the secretariat to the National Digital Economy and 4IR Council, chaired by the Prime Minister, and hosts the Malaysia Centre for the Fourth Industrial Revolution (MYCentre4IR) in collaboration with the World Economic Forum. MyDIGITAL Corporation is a dynamic platform aimed at accelerating the digital transformation and adoption of 4IR technologies and fostering innovation.
Website : MyDIGITAL Corporation | Follow us at Facebook | Instagram | LinkedIn | X

About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

Photo – https://laotiantimes.com/wp-content/uploads/2026/04/oracle_helps_drive_malaysia_s_digital_innovation_ambition.jpg
Logo – https://laotiantimes.com/wp-content/uploads/2026/04/oracle_logo_logo.jpg

BANGKOK, April 2, 2026 /PRNewswire/ — As the ‘T-Beauty’ trend continues its unstoppable growth, ‘EVEANDBOY’, Thailand’s number one beauty store, is seizing this opportunity by organizing the ‘EVEANDBOY T-BEAUTY FEST’. This event is designed to strengthen and elevate Thai brands to the global stage, as well as to support Thai entrepreneurs in sustainably expanding their markets internationally, firmly establishing Thailand as an outstanding beauty hub that is second to none in the world.

The overall market for Thai beauty brands, commonly known as ‘T-Beauty’ Products of Thailand, continues to maintain significant growth. It is not merely a brief trend that comes and goes. In fact, over the past four to five years, Thai skincare and cosmetics brands have seen exponential growth in both revenue and their customer base, alongside the emergence of dozens of new brands. According to data from the President of the Thai Cosmetic Cluster Trade Association, the Thai cosmetics industry has been expanding continuously. Its market value has surged from approximately 70 billion baht 20 years ago to 400 billion baht in 2025. This steady growth rate of 6 to 7 percent reflects that Thai brands have strong potential to compete in both domestic and international markets.

‘EVEANDBOY’, the first Thai beauty store with nearly 20 years of industry expertise, recognized the opportunity to support and bring together the outstanding qualities of Thai brands in a single location. Thus, the ‘EVEANDBOY T-BEAUTY FEST’ was created to serve as ‘The World’s T-Beauty Destination’, allowing both Thai and international visitors to fully experience and discover Thai brands in depth. The event also proclaims the magnitude of Thai brands, ensuring they are not just products favored by locals, but that they also achieve a ‘T-Beauty Must Buy’ status, making these cosmetics essential iconic national souvenirs for foreign tourists to take home.

Mr. Hiran Tanmit, CEO of EVEANDBOY Co., Ltd., stated that this event aims to bring Thai brands together in a single location and ensure both Thai and international customers can test products, take advantage of shopping promotions, and discover a diverse array of Thai brands. The ultimate goal is to create a platform that strengthens the image of ‘T-Beauty’ Products of Thailand. He believes that this event will play a crucial role in elevating the overall ‘T-Beauty’ industry. Today, Thai brands are truly outstanding, boasting world-class quality and their own unique potential. Therefore, this is the perfect time to unite Thai brands to generate ‘T-Beauty Power’.

“As EVEANDBOY is the pioneer Thai beauty store with a long-standing presence in the market, and the first beauty retailer to assemble the largest collection of Thai brands, we recognize that ‘T-Beauty’ Products of Thailand, has shown clear advancement in terms of quality, innovation, and consumer understanding. Today, T-Beauty covers a diverse range of categories, including cosmetics, skincare, fragrances, dietary supplements, and beauty accessories. EVEANDBOY carries 600 T-Beauty brands with over 30,000 items. From 2022 to 2025, EVEANDBOY sold over 100 million T-Beauty items, achieving a growth rate 2.5 times higher than in 2022. This reflects that T-Beauty is not just a short-term trend, but is actually experiencing strong growth. In the future, T-Beauty still has significant room to grow, driven by both domestic consumer demand and its expansion into tourist groups and international markets that are increasingly taking an interest in Thai brands.”

Even though this is the golden era for ‘T-Beauty’ Products of Thailand, foreign brands are entering our domestic market with equal intensity. Mr. Hiran believes that the key factors helping Thai entrepreneurs stand out amidst this fierce competition are innovation and a quick response to consumer needs, as well as brand image, product quality, ingredients, creativity, and reasonable pricing. All of these are inherent strengths that Thai brands can leverage to further develop their products to perfectly match consumer demands.

At the same time, the strategy of selecting Asian or global brand presenters, together with compelling ‘brand storytelling’, serves as another crucial tactic for expanding the customer base. This approach is particularly effective for reaching both Asian and international fan bases. All of these factors play a significant role in seamlessly helping ‘T-Beauty’ Products of Thailand, grow to rival foreign brands.

The objective of the ‘EVEANDBOY T-BEAUTY FEST’ is to elevate the image of Thai brands, reinforce the high quality of ‘T-Beauty’ Products of Thailand, and generate the widest possible word of mouth and discussion among both Thai and international consumers. According to the Tourism Authority of Thailand (TAT) regarding foreign tourist arrivals in 2025, Malaysia ranked first with an impressive 4.8 million visitors, followed by China with 4.6 million, India with 2.1 million, Russia with 1.8 million, and South Korea with 1.6 million. This is a great opportunity to transform ‘T-Beauty’ into a ‘T-Beauty Must Buy’ status, ensuring that anyone who visits Thailand will purchase Thai cosmetics to take home with them.

The CEO added that, based on the database of international shoppers at ‘EVEANDBOY’, there is a clear shift in purchasing behavior, particularly in actively seeking out ‘T-Beauty’ Products of Thailand, viewing them as items that reflect a distinct Thai identity with highly unique characteristics. Thai brands have achieved standards comparable to their foreign counterparts and are widely praised as products of excellent quality that feature contemporary innovation and come at reasonable prices, leading to significant word of mouth among international consumers. He believes that Thai brands possess a clear opportunity to easily grow into global brands in the future.

“While numerous foreign brands have previously entered the market, we were the first to assemble the most extensive collection of Thai brands. We have a long history of understanding and championing them, and we firmly believe that Thai cosmetics offer quality comparable to international brands at reasonable prices. We want to see positive word of mouth spread among both Thai and international consumers, leading to repeat purchases. Our goal is to ensure that anyone who visits Thailand will buy products from EVEANDBOY to take home, driven by their confidence in the quality of Thai brands. This reflects the true potential of ‘T-Beauty’ Products of Thailand, to achieve strong and sustainable growth on a global scale. Anyone interested in ‘T-Beauty’ Products of Thailand must come to EVEANDBOY. We are fully prepared to elevate Thai brands to the global stage.”

Stay updated on special activities from EVEANDBOY by following us on Facebook: EVEANDBOY, Instagram: EVEANDBOY, TikTok: EVEANDBOY, X: EVEANDBOY, Lemon 8: EVEANDBOY, Xiaohongshu: EVEANDBOY, Weibo: EVEANDBOY, and Douyin: EVEANDBOY.

#EVEANDBOYTBEAUTY #EVEANDBOY #ILoveTBeauty
#THAILAND #Tbeauty #thaibeauty

SINGAPORE, April 2, 2026 /PRNewswire/ — For decades, beer ads have belonged to the big guys, million-dollar productions, glossy beaches and celebrity cameos that cost more than a craft brewery makes in a year. For independent brewers like Brewlander, it was never a fair fight. Until now.

With the rise of text-to-video AI like Sora and Qwen 2.5, the rules have changed. Today, anyone with a keyboard can make an epic film without spending a cent. So Brewlander decided to do just that.

To show how Brewlander is the beer that invests in the beer, the brand didn’t film commercials, it printed them. Posters, billboards, magazines, all featuring detailed AI prompts that anyone could type in to instantly generate over-the-top beer ads. The kind of ads independent brewers were never supposed to afford.

Examples included:

“Surfers ride black sea horses through an underwater world of neon coral reefs, past glowing jellyfish, raising their ice-cold Brewlanders.”

“A colossal Brewlander bottle floats in a galaxy of bubble-planets and star-balls.”

To make it even more rewarding, fans who generated their own Brewlander ads received exclusive discounts on the beer.

At the end of the day, the message was a brilliant move: Brewlander doesn’t invest in million-dollar commercials, it invests in what matters: the beer itself.

About Brewlander

Brewlander was born out of John’s passion for homebrewing (and his online moniker on brewing forums), and we’ve kept that homebrew tradition of having fun and pushing the envelope well alive.

Back in 2016, John and a few friends came up with a wild idea: to make his award-winning brews available to the wider public. Taking a leap of faith, he gave up his day job and plunged headfirst into the project with the mission to challenge the status quo of Asia’s beer scene, while putting Singaporean brews on the world beer map.

Brewlander splashed onto Singapore’s craft beer scene on 14 March 2017, launching to glowing response from the local beer community and the media as Singapore’s first gypsy brewer.

About BLKJ Havas

BLKJ Havas is a creative company that engineers marketing moments for brands in culture, entertainment and media. It prides itself as the un-advertising agency – because people hate advertising, and we love people.

Now more than 8 years in business, the agency is amongst the most awarded and successful in the region. It is currently ranked the #1 Agency in Singapore, #8 in Asia by Campaign Brief THE WORK 2024. It is Spikes Asia 2024’s Singapore Agency of the Year, and Top 10 APAC Agency of the Year.

Its strong regional and Singapore client roster includes Reckitt, JLL, JBL Harman, Great Eastern, Land Transport Authority of Singapore, Republic of Singapore Air Force, Singapore Tourism Board, Ministry of Education Singapore, IMDA and more.

For more, check out: blkjhavas.agency

• Preclinical research on Caliway’s fat reduction drug candidate CBL-514 in combination with GLP-1R-based weight-loss therapies has been selected for presentation at the American Diabetes Association’s 2026 Scientific Sessions.
• The presentation will be delivered by W. Timothy Garvey, MD, a globally recognized authority in obesity and metabolic medicine and a scientific advisor to Caliway.
• The American Diabetes Association’s Scientific Sessions is one of the world’s largest and most influential scientific meetings in diabetes and obesity, and the American Diabetes Association’s Standards of Care are widely regarded as a global clinical standard.
• Selection for presentation at the American Diabetes Association’s Scientific Sessions, one of the leading flagship scientific meetings in diabetes, obesity, and metabolism, reflects the research direction and application potential of CBL-514 in combination with GLP-1R-based weight-loss therapies, and has gained strong recognition from international experts in metabolism.
• Caliway also plans to engage face-to-face with global experts, academics, and multinational pharmaceutical companies during the meeting to further strengthen its global strategic development.

TAIPEI, April 2, 2026 /PRNewswire/ — Caliway Biopharmaceuticals (TWSE: 6919), a clinical-stage biopharmaceutical company advancing innovative small-molecule therapies in aesthetic medicine, metabolic diseases, and other unmet medical needs, announced that the latest preclinical data on its first-in-class large-area localized fat reduction drug candidate, CBL-514, in combination with GLP-1R-based therapies, has been selected for presentation at the 2026 Scientific Sessions of the American Diabetes Association®(ADA), one of the leading flagship scientific meetings in diabetes, obesity, and metabolism worldwide. Caliway’s research has also been selected for presentation at both ECO, the European Congress on Obesity, and the ADA’s two premier scientific meetings in obesity and metabolism in Europe and the United States. This highlights the research direction of CBL-514 in combination with GLP-1R-based weight-loss therapies, including its potential complementary value in metabolic parameters, and reflects strong recognition and attention from international experts in metabolism.

The ADA’s 2026 Scientific Sessions will be held from June 5 to June 8, in New Orleans, Louisiana, U.S. The presentation will be delivered by W. Timothy Garvey, MD, a globally recognized authority in obesity and metabolic medicine and a scientific advisor to Caliway. Dr. Garvey is Professor of Endocrinology and Obesity Medicine at the University of Alabama at Birmingham (UAB). He has long been engaged in the fields of obesity, metabolic disease, and cardiometabolic risk, and has made important contributions to multiple U.S. clinical guidelines related to obesity and metabolism. He is highly regarded in the global weight management field. In addition, Dr. Garvey has also been invited to serve as a scientific advisor to multiple multinational pharmaceutical companies, including Eli Lilly and Novo Nordisk. His role as the presenter further enhances Caliway’s visibility and representation as it expands from localized fat reduction into the global obesity and metabolic medicine field.

The title of the selected abstract is:

“Combination of Tirzepatide with CBL-514 an Adipocyte-Apoptosis Agent Improves Weight Loss Durability and Adipose Tissue Remodeling in Diet-Induced Obese Rats.”

The ADA is an internationally authoritative non-profit medical organization. Its annual Standards of Care in Diabetes are widely regarded as a global clinical standard. The ADA Scientific Sessions is also one of the world’s largest and most influential scientific meetings in diabetes, bringing together more than 12,000 researchers and clinicians, including physicians, nurses, endocrinologists, cardiologists, registered dietitian nutritionists, and others. It serves as a premier global platform for presenting cutting-edge basic research and new drug development progress.

Vivian Ling, CEO of Caliway, stated, “The selection of Caliway’s research on CBL-514 in combination with GLP-1R-based weight-loss therapies for presentation at one of the world’s largest medical meetings in obesity and diabetes, with a globally influential KOL such as Dr. Garvey serving as the presenter, reflects continued recognition of the Company’s research direction in obesity and metabolism by the global professional community. It also highlights the potential value and international competitiveness of CBL-514 in key focus areas of global obesity medicine, including improving weight-loss durability and optimizing adipose tissue remodeling.”

In addition to presenting the latest scientific progress at the meeting, Caliway will also actively take this opportunity to meet face-to-face with global experts in obesity and metabolism, as well as multinational pharmaceutical companies, to further expand and deepen the global development strategy and collaboration opportunities for CBL-514.

About CBL-514
CBL-514, a 505(b)(1) and first-in-class small-molecule drug developed by Caliway, is the world’s first injectable lipolysis drug that induces adipocyte apoptosis to reduce subcutaneous fat in targeted areas with no systemic safety risks identified and good tolerability.

To date, 10 clinical trials with a total of 544 subjects have been completed with all efficacy and safety endpoints met.

CBL-514 is being developed across multiple indications, including reduction of subcutaneous fat (non-surgical localized fat reduction) and moderate-to-severe cellulite. CBL-514D, the same active pharmaceutical ingredients (APIs) but under different formulation, is being studied for additional indications such as Dercum’s disease and more.

About Caliway Biopharmaceuticals
Caliway Biopharmaceuticals (Caliway) is a clinical-stage biopharmaceutical company driven to breakthrough drug discovery of novel small-molecule therapeutics. Listed on the Taiwan Exchange (TWSE-6919), Caliway aims to become an innovative pharmaceutical leader in aesthetic medicine and other diseases. For more information, please visit: https://www.caliwaybiopharma.com/en/

Media Contact
ir@caliwaybiopharma.com

Disclaimer
This article and related information on this site contain forward-looking statements. The forward-looking information requires the Company to make numerous assumptions and is subject to inherent risks, uncertainties, and other factors that are beyond the control of the Company which may cause actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. The Company undertakes no obligation to timely inform, update, or revise the information on this site if circumstances should change.